Skip to main content
New Year’s Sale — Build a balanced news diet with 40% off Vantage
Get Started
SubscribeLogin
Published • loading... • Updated

Biopharmaceuticals Boost Their Investment in Acquisitions by 36%

Summary by Expansión
The volume of agreements reached by the health industry exceeds 454,630 million, thanks to groups such as Kimberly-Clark, Abbott, J&J, Novartis, Takeda, BMS and Merck-MSD. Read
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

ExpansiónExpansión

Biopharmaceuticals Boost Their Investment in Acquisitions by 36%

The volume of agreements reached by the health industry exceeds 454,630 million, thanks to groups such as Kimberly-Clark, Abbott, J&J, Novartis, Takeda, BMS and Merck-MSD. Read

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Expansión broke the news in on Friday, January 2, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Johnson & Johnson icon

Johnson & Johnson

Spain icon

Spain

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal